Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab

Authors

  • Surina Frey
  • Benjamin Kendziora
  • Julian Walter Holch
  • Lars Lindner
  • Lars E. French
  • Andreas Wollenberg Department of Dermatology and Allergy, University Hospital of Munich (LMU), DE-80337 Munich, Germany

DOI:

https://doi.org/10.2340/00015555-3734

Keywords:

atopic dermatitis, dupilumab, immune thrombocytopenic purpura, ITP, thrombocytopenia

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, Kunz B, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol 2016; 30: 729-747.

DOI: https://doi.org/10.1111/jdv.13599

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol 2018; 32: 850-878.

DOI: https://doi.org/10.1111/jdv.14888

Seegraber M, Srour J, Walter A, Knop M, Wollenberg A. Dupilumab for treatment of atopic dermatitis. Expert Rev Clin Pharmacol 2018; 11: 467-474.

DOI: https://doi.org/10.1080/17512433.2018.1449642

Wollenberg A, Beck LA, Blauvelt A, Simpson EL, Chen Z, Chen Q, et al. Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). Br J Dermatol 2020; 182: 1120-1135.

DOI: https://doi.org/10.1111/bjd.18434

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 2016; 375: 2335-2348.

DOI: https://doi.org/10.1056/NEJMoa1610020

Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 2013; 27: 137-145.

DOI: https://doi.org/10.1016/j.tmrv.2013.05.005

Perera M, Garrido T. Advances in the pathophysiology of primary immune thrombocytopenia. Hematology 2017; 22: 41-53.

DOI: https://doi.org/10.1080/10245332.2016.1219497

Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol 2003; 71: 283-288.

DOI: https://doi.org/10.1034/j.1600-0609.2003.00138.x

Senner S, Eicher L, Aszodi N, Prinz JC, French LE, Wollenberg A. Psoriasis bei Dupilumab-behandeltem atopischem Ekzem. Hautarzt 2020; 71: 383-386.

DOI: https://doi.org/10.1007/s00105-020-04565-8

Downloads

Published

2021-03-09

How to Cite

Frey, S., Kendziora, B., Holch, J. W., Lindner, L., French, L. E., & Wollenberg, A. (2021). Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab. Acta Dermato-Venereologica, 101(3), adv00409. https://doi.org/10.2340/00015555-3734

Issue

Vol. 101 No. 3 (2021): March

Section

Short Communication

Categories

License

Copyright (c) 2021 Surina Frey, Benjamin Kendziora, Julian Walter Holch, Lars Lindner, Lars E. French, Andreas Wollenberg

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC